Infusion Therapy Is Moving Out of Hospitals
The home infusion and ambulatory infusion therapy market has been one of the fastest-growing segments in post-acute healthcare over the past five years. A 2024 report from the National Home Infusion Association (NHIA) valued the U.S. home infusion market at approximately $18 billion annually, with growth driven by payer incentives to shift intravenous therapy — including antibiotics, biologics, immunoglobulin, and total parenteral nutrition — away from higher-cost hospital settings.
That growth is creating operational challenges for infusion therapy companies. Each new patient requires a referral intake, insurance benefits investigation, prior authorization, nursing assessment, drug dispensing, and ongoing care coordination. The administrative components of that workflow are substantial, and the nursing and clinical shortage means licensed staff cannot absorb them without compromising clinical capacity.
The Referral-to-Treatment Administrative Chain
The journey from referral receipt to first infusion involves multiple administrative steps that do not require clinical licensure but do require careful execution:
Referral Intake and Triage Infusion referrals arrive from hospitals, oncology practices, rheumatology offices, and other prescribing environments. VAs receive referrals, verify completeness, enter patient demographic and clinical information into infusion management software, and flag missing items for follow-up with the referring provider.
Benefits Investigation Before scheduling a patient's first infusion, companies must verify insurance coverage, confirm infusion-specific benefits, identify any site-of-care restrictions, and document patient out-of-pocket liability. VAs conduct these benefit investigations across commercial, Medicare, and Medicaid plans.
Prior Authorization Submission and Tracking Most infusion drugs — particularly biologics for rheumatoid arthritis, Crohn's disease, and multiple sclerosis — require prior authorization. VAs compile clinical documentation, submit PA requests, track approval status, and escalate denials to clinical coordinators for appeal.
Patient Scheduling and Logistics Coordination Once authorized, infusion appointments must be scheduled, nursing visits coordinated, and drug shipments aligned with treatment dates. For home infusion, this requires coordinating between the pharmacy, nursing agency, and patient. VAs manage this scheduling and logistics layer, confirming all parties are aligned before treatment day.
Ongoing Refill and Reauthorization Management Infusion therapy patients are often on long-term treatment regimens requiring periodic insurance reauthorization. VAs track reauthorization timelines, initiate resubmissions ahead of expiration, and manage refill coordination to prevent treatment gaps.
The Business Case Is Clear
Infusion therapy companies operate with a complex mix of pharmacy, nursing, and administrative costs. According to a 2024 Definitive Healthcare analysis of home infusion providers, administrative and intake labor represents 20–28% of total operating cost for most mid-size infusion companies. Virtual assistants — particularly in nearshore markets — can perform administrative intake and coordination functions at 40–50% lower cost than domestic equivalents.
Beyond cost, speed matters. NHIA benchmarking data from 2024 found that infusion companies with streamlined administrative intake processes — including dedicated intake coordinators — had median time-from-referral-to-first-infusion of 4.2 days, compared to 7.1 days for companies without structured intake support. For patients with time-sensitive conditions, that difference is clinically meaningful.
Compliance Requirements
Infusion therapy companies handle PHI extensively throughout the care coordination process. HIPAA-compliant VA partnerships with signed BAAs are essential. Additionally, some infusion drugs carry FDA REMS requirements, and VAs involved in REMS-adjacent documentation must be trained on those requirements.
Infusion management platforms — including Brightree, HHAeXchange, and WellSky — require platform-specific training for VAs to be effective. Successful deployments invest in structured onboarding before VAs go live with patient-facing workflows.
Stealth Agents offers virtual assistants experienced in healthcare coordination environments, including referral intake, benefits investigation, and prior authorization management for infusion and specialty care companies.
Growing Demand Will Require Scalable Operations
As biologic therapies continue to expand the infusion-eligible patient population and payers accelerate home-infusion incentives, volume growth will continue. Infusion companies that build scalable administrative infrastructure — including virtual assistant teams — now will be better positioned to grow without the operational bottlenecks that limit many mid-size providers.
Sources
- National Home Infusion Association, "Home Infusion Market Report 2024," nhia.org
- Definitive Healthcare, "Home Infusion Provider Operations Analysis 2024," definitivehc.com
- NHIA, "Referral-to-Treatment Benchmarking Survey 2024," nhia.org
- Centers for Medicare and Medicaid Services, "Home Infusion Therapy Benefit Overview," cms.gov
- U.S. Food and Drug Administration, "REMS Programs by Drug," fda.gov